Dnaprint Genomics Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Gannon Daniel, was filed 13 Jan 2009.
Dnaprint Genomics Inc: what insiders have been doing
Every trade that managers of Dnaprint Genomics Inc disclose to SEC (Form 4) is tracked on this page. Dnaprint Genomics Inc has had no insider filing for more than a year; the last one goes back to 13 January 2009.
Since 2008, the database holds 34 purchases and no sales by insiders of the company.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Since the insiders bought
- +20.0%Entry US$0.00 · Close at T+365 US$0.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
· cache
- 465,274 shares@ US$0.0004Common StockSEC:0001443865-09-000003:0Canonical exit: 2 Apr 2009 (T+90)
- 513,000 shares@ US$0.0004Common StockSEC:0001443865-09-000003:1Canonical exit: 6 Apr 2009 (T+90)
- 21,475 shares@ US$0.0004Common StockSEC:0001443865-09-000001:0Canonical exit: 29 Mar 2009 (T+90)
- 153,350 shares@ US$0.0004Common StockSEC:0001443865-09-000001:1Canonical exit: 30 Mar 2009 (T+90)
- 686,802 shares@ US$0.0004Common StockSEC:0001443865-09-000001:2Canonical exit: 31 Mar 2009 (T+90)
- 98,900 shares@ US$0.0003Common StockSEC:0001443865-08-000015:0Canonical exit: 22 Mar 2009 (T+90)
- 2,771,177 shares@ US$0.0004Common StockSEC:0001443865-08-000015:1Canonical exit: 22 Mar 2009 (T+90)
- 1,169,700 shares@ US$0.0004Common StockSEC:0001443865-08-000015:2Canonical exit: 23 Mar 2009 (T+90)
- 1,328,000 shares@ US$0.0004Common StockSEC:0001443865-08-000015:3Canonical exit: 26 Mar 2009 (T+90)
- 114,387 shares@ US$0.0004Common StockSEC:0001443865-08-000014:0Canonical exit: 15 Mar 2009 (T+90)
- 3,024,000 shares@ US$0.0004Common StockSEC:0001443865-08-000014:1Canonical exit: 16 Mar 2009 (T+90)
- 849,475 shares@ US$0.0004Common StockSEC:0001443865-08-000014:2Canonical exit: 17 Mar 2009 (T+90)
- 258,880 shares@ US$0.0004Common StockSEC:0001443865-08-000014:3Canonical exit: 18 Mar 2009 (T+90)
- 650,000 shares@ US$0.0004Common StockSEC:0001443865-08-000014:4Canonical exit: 19 Mar 2009 (T+90)
- 4,227,658 shares@ US$0.0004Common StockSEC:0001443865-08-000012:0Canonical exit: 11 Mar 2009 (T+90)
- 70,925 shares@ US$0.0004Common StockSEC:0001443865-08-000012:1Canonical exit: 12 Mar 2009 (T+90)
- 1,000,000 shares@ US$0.0004Common StockSEC:0001443865-08-000011:0Canonical exit: 3 Mar 2009 (T+90)
- 500 shares@ US$0.0004Common StockSEC:0001443865-08-000010:0Canonical exit: 19 Feb 2009 (T+90)
- 177,000 shares@ US$0.0004Common StockSEC:0001443865-08-000010:1Canonical exit: 23 Feb 2009 (T+90)
- 92,000 shares@ US$0.0004Common StockSEC:0001443865-08-000009:0Canonical exit: 9 Feb 2009 (T+90)
- 20,000 shares@ US$0.0004Common StockSEC:0001443865-08-000009:1Canonical exit: 11 Feb 2009 (T+90)
- 14,457,175 shares@ US$0.0004Common StockSEC:0001443865-08-000009:2Canonical exit: 17 Feb 2009 (T+90)
- 768,322 shares@ US$0.0004Common StockSEC:0001443865-08-000009:3Canonical exit: 18 Feb 2009 (T+90)
- 15,371,035 shares@ US$0.0004Common StockSEC:0001443865-08-000006:0Canonical exit: 28 Jan 2009 (T+90)
- 21,595,000 shares@ US$0.0004Common StockSEC:0001443865-08-000006:1Canonical exit: 29 Jan 2009 (T+90)
25 of 34 declarations
About Dnaprint Genomics Inc
Dnaprint Genomics Inc is a genomics company that provides solutions based on DNA analysis. It is listed on the NASDAQ.
